Interferon-γ (IFN-γ); IL-17; nuclear receptor subfamily 4, group A, member 2 (NR4A2) BriefCommunication Pages: 521 - 521
Kinase inhibitor of nuclear factor-κB-1 (KINK-1); IκB kinase-β (IKKβ); NF-κB BriefCommunication Pages: 527 - 527
Pituitary adenylate cyclase–activating peptide (PACAP); proopiomelanocortin (POMC); β-endorphin (BEP) BriefCommunication Pages: 528 - 528
Cyclic guanosine monophosphate–dependent protein kinase (PKG); cyclic guanosine monophosphate phosphodiesterase (cGMP-PDE) BriefCommunication Pages: 530 - 530
Glial cell–derived neurotrophic factor (GDNF); mitogen-activated protein kinase (MAPK) BriefCommunication Pages: 534 - 534
Apoptosis signal–regulating kinase 1 (ASK1); derlin-1; superoxide dismutase 1 (SOD1) BriefCommunication Pages: 535 - 535
Stromal cell–derived factor-1α (SDF-1α); CXC chemokine receptor 4 (CXCR4); cellular prion protein (PrPc) BriefCommunication Pages: 537 - 537
1-(2′-Deoxy-2′-[18F]fluoroarabinofuranosyl) cytosine ([18F]FAC) PET to monitor immune function BriefCommunication Pages: 538 - 538
Fluorescence-activated cell sorting (FACS) to select targeted nucleic acid aptamers BriefCommunication Pages: 539 - 539